NeuroBridge

NeuroBridge Biotechnology is a specialized preclinical research organization based in Guangzhou, China, focused on non-human primate (NHP) and pig disease models and exploratory non-GLP translational studies. We support customized model development and application across neurodegenerative, neurodevelopmental, rare disease and oncology programs. Core capabilities include stereotactic intracranial delivery, intrathecal/ICV/ICM administration, AAV and gene therapy evaluation, efficacy and PK/PD studies, target engagement, biodistribution, behavioral assessment, biomarker analysis, molecular imaging and histopathology endpoints. Founded in 2023, our team brings more than 10 years of experience in large-animal disease-model development and provides sponsor-tailored study design, execution and data analysis. NeuroBridge accepts both exploratory non-GLP and GLP study programs. GLP components are delivered through qualified GLP partner facilities, with study scope, quality requirements and regulatory responsibilities defined for each project.